Tilkynning frá OMX | 20.3.

Ossur Hf : Transactions in relation to share buyback program

Announcement from Össur hf. No. 25/2017
Reykjavík, 20 March 2017

On 1 December 2016, Össur hf. initiated a new share buy-back program, see
Company announcement no. 96/2016.

The purpose of the share buyback program is to reduce the Company's share
capital and adjust the capital structure by distributing capital to shareholders
in line with the Company's Capital Structure and Dividend Policy. The program
will end no later than 30 November 2017. The Company may purchase up to
5,000,000 shares under the program, corresponding to 1.2% of the current share
capital. The total consideration for shares purchased under the program shall
not exceed USD 10 million (approx. DKK 70 million).

The following transactions have been made under the program in week 15, the
period 13 March 2017 - 17 March 2017:

 Date No. of shares Avg. purchase price DKK Transaction Value DKK
 13 March 2017 19,729 26.66 526,068

 14 March 2017 17,435 26.14 455,787

 15 March 2017 5,745 25.96 149,153

 16 March 2017 500 25.70 12,850

 17 Mach 2017 - - -
 Total   43,409 26.35 1,143,858

Össur has acquired 558,533 shares under the program at the average price of DKK
25.20. Following the above transactions Össur's holding of own shares is
12,497,840 corresponding to 2.82% of the Company's total share capital.

The share buyback program on Nasdaq Copenhagen is carried out in accordance with
Regulation No. 596/2014 of the European Parliament and of the Council on market
abuse ("MAR"), and the Commission delegated regulation No. 2016/1052.

Contact persons:
Jón Sigurðsson, President & CEO                                          Tel:
+354 515 1300
Sveinn Sölvason, CFO
Tel: +354 515 1300

Össur press releases by e-mail

If you wish to receive Össur press releases by e-mail please register at the
following web-site: http://www.ossur.com/investormailings

About Össur Össur (NASDAQ: OSSR) is a global leader in non-invasive orthopedics
that help people live a life without limitations. Its business is focused on
improving people's mobility through the delivery of innovative technologies
within the fields of braces, supports and prosthetic limbs. A recognized
"Technology Pioneer", Össur invests significantly in research and product
development; its award-winning designs ensuring a consistently strong position
in the market. Successful patient and clinical outcomes are further empowered
via Össur's educational programs and business solutions.  Headquartered in
Iceland, Össur has major operations in the Americas, Europe and Asia, with
additional distributors worldwide. www.ossur.com

Forward-Looking Statement This press release includes "forward-looking
statements" which involve risks and uncertainties that could cause actual
results to differ materially from results expressed or implied by these
statements. Össur hf. undertakes no obligation and does not intend to update
these forward-looking statements to reflect events or circumstances occurring
after this press release. You are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date of this press
release. All forward-looking statements are qualified in their entirety by this
cautionary statement.

Share buy back transactions 13.03-17.03 2017: 

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Ossur Hf via GlobeNewswire